经皮肾活检：方法、诊断准确性和风险。
Percutaneous renal biopsy: approach, diagnostic accuracy and risks.
机构信息
Department of Urology, University of California Irvine, Irvine, California, USA.
出版信息
Curr Opin Urol. 2018 Jul;28(4):369-374. doi: 10.1097/MOU.0000000000000505.
PURPOSE OF REVIEW
This article provides a review of recent advances and issues regarding the controversial topic of renal mass biopsy (RMB). The purpose of this review is to provide an update on the current status of renal biopsy based on recently published literature. Here, we particularly focus on articles that have been published within the last 12 months.
RECENT FINDINGS
The main topics covered in this review are the approach, diagnostic accuracy and risks related to RMB.
SUMMARY
Current literature suggests that improvements in both technique and technological advancements of RMB have led to greater diagnostic accuracy and low risks to the patient. Newer technologies are leading toward innovative and harmless ways to diagnose kidney cancer, including liquid and image-based biopsy. However, it appears that the question of whether or not to instate renal biopsy as standard clinical practice has remained a highly debated controversy.
目的综述
本文综述了肾肿瘤活组织检查（RMB）这一具有争议性话题的最新进展和问题。本文的目的是根据最近发表的文献，对目前的肾活检现状进行更新。在此，我们特别关注在过去 12 个月内发表的文章。
最近的发现
本综述涵盖的主要主题包括 RMB 的方法、诊断准确性和风险。
总结
目前的文献表明，RMB 技术和技术进步的改进导致了更高的诊断准确性和对患者的低风险。新技术正在引领创新和无害的方法来诊断肾癌，包括液体和基于图像的活检。然而，是否将肾活检作为标准临床实践的问题似乎仍然是一个极具争议的话题。
Zotero 插件